2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum
Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.
Previous
Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases
Next